TITLE:
      Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
SUMMARY:
      This trial is conducted in the United States of America (USA). This trial aims for a
      comparison of the safety and efficacy in subjects with type 2 diabetes using either self
      titration or physician guided titration according to the local standard of care.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Diagnosis of type 2 diabetes HbA1C <= 12.0% within the past 12 months;

          -  BMI <= 45.0 kg/m2

          -  Initiation, addition of, change to, or continuation of basal insulin therapy with
             insulin detemir as deemed necessary by Investigator

        Exclusion Criteria:

          -  Anticipated change in concomitant medication known to interfere with glucose
             metabolism such as systemic steroids, non-selective beta-blockers or mono amine
             oxidase (MAO) inhibitors.

          -  Proliferative retinopathy or maculopathy that has required acute treatment within the
             last 6 months.

          -  Any glucose lowering medication that is not indicated in combination with insulin,
             such as GLP-1 Analogues

          -  Known hypoglycemia unawareness or recurrent major hypoglycemia, as judged by the
             Investigator
